Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trophoblasts | 6 | 2022 | 113 | 1.670 |
Why?
|
| Embryonic Stem Cells | 6 | 2017 | 163 | 1.160 |
Why?
|
| Chromosome Disorders | 2 | 2023 | 311 | 0.740 |
Why?
|
| DNA Copy Number Variations | 4 | 2025 | 963 | 0.720 |
Why?
|
| Genetic Testing | 4 | 2024 | 1016 | 0.690 |
Why?
|
| Prenatal Diagnosis | 2 | 2022 | 601 | 0.680 |
Why?
|
| Histones | 4 | 2016 | 542 | 0.620 |
Why?
|
| Chromosome Aberrations | 2 | 2018 | 620 | 0.600 |
Why?
|
| Genetic Markers | 1 | 2019 | 605 | 0.570 |
Why?
|
| Placenta | 3 | 2022 | 508 | 0.560 |
Why?
|
| Gene Duplication | 1 | 2018 | 363 | 0.530 |
Why?
|
| Gene Deletion | 1 | 2018 | 793 | 0.480 |
Why?
|
| Cell Differentiation | 4 | 2014 | 1909 | 0.450 |
Why?
|
| Single-Cell Analysis | 3 | 2021 | 288 | 0.410 |
Why?
|
| Genetic Loci | 1 | 2013 | 342 | 0.380 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 1294 | 0.350 |
Why?
|
| Proteomics | 4 | 2017 | 506 | 0.330 |
Why?
|
| Pregnancy | 9 | 2023 | 7226 | 0.320 |
Why?
|
| Cell Separation | 2 | 2020 | 230 | 0.310 |
Why?
|
| Vulnerable Populations | 2 | 2024 | 136 | 0.240 |
Why?
|
| CADASIL | 1 | 2024 | 7 | 0.230 |
Why?
|
| Glutarates | 1 | 2024 | 37 | 0.230 |
Why?
|
| Paraganglioma | 1 | 2024 | 20 | 0.230 |
Why?
|
| Mediator Complex | 1 | 2024 | 52 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2024 | 57 | 0.220 |
Why?
|
| Brain Abscess | 1 | 2024 | 50 | 0.220 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2024 | 151 | 0.210 |
Why?
|
| Cell Line | 5 | 2016 | 2757 | 0.210 |
Why?
|
| Proteolysis | 2 | 2014 | 172 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 2 | 2022 | 1763 | 0.210 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2024 | 118 | 0.210 |
Why?
|
| Hemiplegia | 1 | 2023 | 45 | 0.210 |
Why?
|
| Humans | 31 | 2025 | 125295 | 0.210 |
Why?
|
| Retinitis Pigmentosa | 1 | 2024 | 84 | 0.210 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2024 | 81 | 0.200 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2024 | 140 | 0.200 |
Why?
|
| Neutropenia | 1 | 2024 | 199 | 0.200 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2024 | 144 | 0.190 |
Why?
|
| Exons | 1 | 2025 | 802 | 0.190 |
Why?
|
| Thrombocytopenia | 1 | 2023 | 225 | 0.190 |
Why?
|
| Metabolomics | 1 | 2024 | 422 | 0.180 |
Why?
|
| Fetus | 2 | 2023 | 586 | 0.180 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2024 | 442 | 0.180 |
Why?
|
| Rare Diseases | 1 | 2023 | 191 | 0.180 |
Why?
|
| Female | 15 | 2024 | 66789 | 0.180 |
Why?
|
| Chemical Fractionation | 2 | 2017 | 13 | 0.170 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2018 | 461 | 0.170 |
Why?
|
| Intellectual Disability | 2 | 2024 | 1054 | 0.170 |
Why?
|
| Pre-Eclampsia | 1 | 2022 | 222 | 0.170 |
Why?
|
| Mutation, Missense | 1 | 2024 | 879 | 0.160 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2024 | 399 | 0.160 |
Why?
|
| Repressor Proteins | 1 | 2024 | 827 | 0.160 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 371 | 0.160 |
Why?
|
| Karyotype | 1 | 2018 | 27 | 0.150 |
Why?
|
| Mass Spectrometry | 2 | 2017 | 335 | 0.150 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 137 | 0.150 |
Why?
|
| Proteome | 2 | 2017 | 246 | 0.150 |
Why?
|
| Young Adult | 3 | 2024 | 9062 | 0.140 |
Why?
|
| Pregnancy Complications | 1 | 2022 | 515 | 0.140 |
Why?
|
| Peptide Library | 1 | 2017 | 57 | 0.140 |
Why?
|
| Maternal Serum Screening Tests | 1 | 2016 | 3 | 0.130 |
Why?
|
| Physicians | 1 | 2023 | 586 | 0.130 |
Why?
|
| Tretinoin | 2 | 2014 | 118 | 0.130 |
Why?
|
| Human Embryonic Stem Cells | 1 | 2016 | 19 | 0.130 |
Why?
|
| Gestational Age | 1 | 2020 | 1169 | 0.130 |
Why?
|
| Culture Media | 1 | 2016 | 181 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 360 | 0.130 |
Why?
|
| Male | 10 | 2024 | 61527 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 887 | 0.120 |
Why?
|
| DNA | 1 | 2021 | 1621 | 0.120 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 653 | 0.120 |
Why?
|
| Adult | 5 | 2024 | 29514 | 0.120 |
Why?
|
| Exome | 3 | 2024 | 1034 | 0.110 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2016 | 573 | 0.110 |
Why?
|
| Leukocyte Elastase | 1 | 2014 | 19 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2020 | 1563 | 0.110 |
Why?
|
| Arginine | 1 | 2016 | 335 | 0.110 |
Why?
|
| beta 2-Microglobulin | 1 | 2013 | 34 | 0.110 |
Why?
|
| Endopeptidases | 1 | 2014 | 116 | 0.110 |
Why?
|
| Activins | 1 | 2013 | 73 | 0.110 |
Why?
|
| Alu Elements | 1 | 2013 | 65 | 0.100 |
Why?
|
| Ribosomal Proteins | 1 | 2013 | 71 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 331 | 0.100 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2014 | 177 | 0.100 |
Why?
|
| Genotype | 1 | 2018 | 2570 | 0.100 |
Why?
|
| Software | 1 | 2017 | 687 | 0.100 |
Why?
|
| Reference Standards | 1 | 2013 | 236 | 0.100 |
Why?
|
| Genes | 1 | 2013 | 447 | 0.100 |
Why?
|
| Germ Cells | 1 | 2013 | 196 | 0.100 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 1756 | 0.080 |
Why?
|
| Infant | 4 | 2024 | 12606 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2017 | 309 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2024 | 8274 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2024 | 16369 | 0.060 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2016 | 42 | 0.060 |
Why?
|
| Mice | 4 | 2014 | 17754 | 0.060 |
Why?
|
| Receptor, Notch3 | 1 | 2024 | 11 | 0.060 |
Why?
|
| Phenotype | 2 | 2024 | 4271 | 0.060 |
Why?
|
| Anus, Imperforate | 1 | 2024 | 20 | 0.060 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2024 | 16 | 0.060 |
Why?
|
| Blepharophimosis | 1 | 2024 | 26 | 0.060 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2024 | 42 | 0.060 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2024 | 64 | 0.060 |
Why?
|
| Facies | 1 | 2024 | 153 | 0.060 |
Why?
|
| Cell Culture Techniques | 2 | 2016 | 276 | 0.060 |
Why?
|
| Genes, X-Linked | 1 | 2024 | 59 | 0.050 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2024 | 71 | 0.050 |
Why?
|
| Blepharoptosis | 1 | 2024 | 67 | 0.050 |
Why?
|
| Constipation | 1 | 2024 | 114 | 0.050 |
Why?
|
| Muscle Hypotonia | 1 | 2024 | 187 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2024 | 150 | 0.050 |
Why?
|
| Mouth Mucosa | 1 | 2023 | 51 | 0.050 |
Why?
|
| Medically Underserved Area | 1 | 2024 | 89 | 0.050 |
Why?
|
| Chromosome Breakage | 1 | 2023 | 167 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2023 | 101 | 0.050 |
Why?
|
| Animals | 5 | 2014 | 34320 | 0.050 |
Why?
|
| Cleft Palate | 1 | 2024 | 142 | 0.050 |
Why?
|
| Eye Proteins | 1 | 2024 | 219 | 0.050 |
Why?
|
| Laboratories | 1 | 2023 | 81 | 0.050 |
Why?
|
| Heterozygote | 1 | 2024 | 672 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 247 | 0.050 |
Why?
|
| Syndrome | 1 | 2024 | 1120 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2025 | 1033 | 0.050 |
Why?
|
| Cells | 1 | 2021 | 27 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 559 | 0.040 |
Why?
|
| Pedigree | 1 | 2024 | 1610 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2024 | 779 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2023 | 348 | 0.040 |
Why?
|
| Mutation | 2 | 2024 | 5905 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 2881 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 245 | 0.040 |
Why?
|
| Biomarkers | 2 | 2022 | 3105 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2024 | 14154 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 605 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2024 | 960 | 0.040 |
Why?
|
| Genome, Human | 1 | 2025 | 1292 | 0.040 |
Why?
|
| Middle Aged | 3 | 2024 | 26726 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2017 | 343 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2016 | 105 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 134 | 0.030 |
Why?
|
| Workflow | 1 | 2016 | 118 | 0.030 |
Why?
|
| Cell Count | 1 | 2016 | 252 | 0.030 |
Why?
|
| Genomics | 1 | 2024 | 1520 | 0.030 |
Why?
|
| Adolescent | 2 | 2024 | 19427 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 234 | 0.030 |
Why?
|
| Vitronectin | 1 | 2014 | 5 | 0.030 |
Why?
|
| Feeder Cells | 1 | 2014 | 9 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2014 | 63 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 122 | 0.030 |
Why?
|
| Embryoid Bodies | 1 | 2013 | 4 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 762 | 0.030 |
Why?
|
| Child | 2 | 2024 | 24625 | 0.030 |
Why?
|
| GATA6 Transcription Factor | 1 | 2013 | 11 | 0.030 |
Why?
|
| Endoderm | 1 | 2013 | 23 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2013 | 38 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2014 | 295 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 3176 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 387 | 0.030 |
Why?
|
| Pluripotent Stem Cells | 1 | 2013 | 71 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2024 | 1832 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 6137 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 802 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 532 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 465 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 2717 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2014 | 887 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 1465 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 3899 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 19704 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 4596 | 0.010 |
Why?
|